Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34,344 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Naturally acquired HPV antibodies against subsequent homotypic infection: A large-scale prospective cohort study.
Yao X, Chen W, Zhao C, Wei L, Hu Y, Li M, Lin Z, Lin B, Liu X, Hong Y, Li Q, Pan Q, Zhang X, Li M, Zhao Y, Zhang L, Xu H, Hu F, Zhao J, Huang Y, Sheng W, Zheng Y, Hu S, Su Y, Huang S, Pan H, Zhao F, Qiao Y, Wu T, Zhang J, Xia N. Yao X, et al. Among authors: zheng y. Lancet Reg Health West Pac. 2021 Jul 16;13:100196. doi: 10.1016/j.lanwpc.2021.100196. eCollection 2021 Aug. Lancet Reg Health West Pac. 2021. PMID: 34527987 Free PMC article.
Safety and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus type 6/11 vaccine: A dose-escalation, randomized, double-blind, placebo-controlled phase 1 trial.
Mo ZJ, Bi ZF, Sheng W, Chen Q, Huang T, Li MQ, Cui XL, Wangjiang YH, Lin BZ, Zheng FZ, Sun G, Li YF, Zheng Y, Zhuang SJ, Su YY, Pan HR, Huang SJ, Wu T, Zhang J, Xia NS. Mo ZJ, et al. Among authors: zheng fz, zheng y. Hum Vaccin Immunother. 2022 Nov 30;18(6):2092363. doi: 10.1080/21645515.2022.2092363. Epub 2022 Jul 14. Hum Vaccin Immunother. 2022. PMID: 35834812 Free PMC article. Clinical Trial.
Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trial.
Hu YM, Bi ZF, Zheng Y, Zhang L, Zheng FZ, Chu K, Li YF, Chen Q, Quan JL, Hu XW, Huang XC, Zhu KX, Wang-Jiang YH, Jiang HM, Zang X, Liu DL, Yang CL, Pan HX, Zhang QF, Su YY, Huang SJ, Sun G, Huang WJ, Huang Y, Wu T, Zhang J, Xia NS. Hu YM, et al. Among authors: zheng y, zheng fz. Sci Bull (Beijing). 2023 Oct 30;68(20):2448-2455. doi: 10.1016/j.scib.2023.09.020. Epub 2023 Sep 19. Sci Bull (Beijing). 2023. PMID: 37743201 Free article. Clinical Trial.
Risk factors in the development of gastric adenocarcinoma in the general population: A cross-sectional study of the Wuwei Cohort.
Chen Z, Zheng Y, Fan P, Li M, Liu W, Yuan H, Liu X, Zhang Z, Wu Z, Wang Y, Ji R, Guo Q, Ye Y, Zhang J, Li X, An F, Lu L, Li Y, Wang X, Zhang J, Guan Q, Li Q, Liu M, Ren Q, Hu X, Lu H, Zhang H, Zhao Y, Gou X, Shu X, Wang J, Hu Z, Xue S, Liu J, Zhou Y. Chen Z, et al. Among authors: zheng y. Front Microbiol. 2023 Jan 12;13:1024155. doi: 10.3389/fmicb.2022.1024155. eCollection 2022. Front Microbiol. 2023. PMID: 36713177 Free PMC article.
34,344 results
You have reached the last available page of results. Please see the User Guide for more information.